← Leaderboards
Kyung Bo Kim
University Of Kentucky
$6,087,977
Attributed
$6,087,977
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $637.1K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,087,977 · 3
By mechanism
R01$6,087,977 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Emmanuel Pinteaux$924,346
- Nicole K Brogden$3,879,442
- Florin Despa$8,791,423
- Russell J Mumper$6,017,636
- Jeffrey Niel Keller$8,674,993
Others in their field
Top investigators on “Toxic Effect”
- George R Seage · Abt Associates, Inc.$224,114,540
- Peter C Adamson · National Childhood Cancer Foundation$126,756,857
- Gregory H Reaman · National Childhood Cancer Foundation$123,836,183
- Carol Nesel · Westat$116,355,411
- Mary M Horowitz · Medical College Of Wisconsin$90,165,506
- Barney Sparrow · Battelle Memorial Institute$88,494,220
Research focus
Toxic EffectIn VivoPeptidesMulticatalytic Endopeptidase ComplexPharmaceutical PreparationsIn VitroAlzheimer&AposSuccessPropertySpecificityLeadSafetyInhibitor/AntagonistMetabolicDrug DiscoveryDrug DevelopmentClinical TrialsBiologicalDoseDrug CandidateClinicDrug TargetingOrganMolecular
Grant awards (15)
Immunoproteasome inhibitors for the treatment of Alzheimers disease$613,991
R01 · FY2025 · AG · contact PI
Immunoproteasome inhibitors for the treatment of Alzheimers disease$626,521
R01 · FY2024 · AG · contact PI
Immunoproteasome inhibitors for the treatment of Alzheimers disease$637,078
R01 · FY2023 · AG · contact PI
Immunoproteasome inhibitors for the treatment of Alzheimerâs disease$616,032
R01 · FY2022 · AG · contact PI
Immunoproteasome inhibitors for the treatment of Alzheimerâs disease$629,282
R01 · FY2021 · AG · contact PI
Non-peptide proteasome inhibitors as a novel anticancer agent$301,390
R01 · FY2018 · CA · contact PI
Non-peptide proteasome inhibitors as a novel anticancer agent$301,809
R01 · FY2017 · CA · contact PI
Non-peptide proteasome inhibitors as a novel anticancer agent$302,228
R01 · FY2016 · CA · contact PI
Non-peptide proteasome inhibitors as a novel anticancer agent$302,647
R01 · FY2015 · CA · contact PI
Non-peptide proteasome inhibitors as a novel anticancer agent$302,120
R01 · FY2014 · CA · contact PI
Chemical Probes of Immunoproteasome Function in Cancer$284,656
R01 · FY2014 · CA · contact PI
Chemical Probes of Immunoproteasome Function in Cancer$276,519
R01 · FY2013 · CA · contact PI
Chemical Probes of Immunoproteasome Function in Cancer$294,520
R01 · FY2012 · CA · contact PI
Chemical Probes of Immunoproteasome Function in Cancer$294,871
R01 · FY2011 · CA · contact PI
Chemical Probes of Immunoproteasome Function in Cancer$304,313
R01 · FY2010 · CA · contact PI